Table 2.
The incubation period for the first episode of imported P. vivax and P. ovale and the interval of relapse or recrudescence from 2014 to 2021 (weeks)
| First episode | Relapse or recrudescence | |||
|---|---|---|---|---|
| P. vivax | P. ovale | P. vivax | P. ovale | |
| Time of onset, n (%) | ||||
| < 5 | 122 (39.87%) | 265 (29.58%) | 1 (3.85%) | 3 (6.12%) |
| 5–12 | 61 (19.93%) | 188 (20.98%) | 5 (19.23%) | 5 (10.2%) |
| 13–24 | 53 (17.32%) | 160 (17.86%) | 5 (19.23%) | 16 (32.65%) |
| 25–52 | 54 (17.65%) | 193 (21.54%) | 10 (38.46%) | 18 (36.73%) |
| 53–78 | 11 (3.59%) | 46 (5.13%) | 5 (19.23%) | 3(6.12%) |
| 79–103 | 4 (1.31%) | 9 (1%) | 0 | 0 |
| > 104 | 1 (0.33%) | 35 (3.91%) | 0 | 4(8.16%) |
| M | 9.14 | 12.43 | 30.43 | 25.43 |
| IQR | 3.14–24.57 | 3.79–30.50 | 13.72–48.00 | 15.86–44.00 |
| Mix | 0.14 | 0 | 4.29 | 4.43 |
| Max | 175 | 265.71 | 69 | 234.43 |